Alperen Vural Selected Research

Alperen Vural Research Topics

4	Ototoxicity 08/2019 - 12/2011
3	Peritonitis 01/2018 - 12/2011
2	Tinnitus 07/2021 - 07/2013
2	Neoplasms (Cancer) 11/2020 - 01/2019
1	Hemorrhage 02/2022
1	Noise-Induced Hearing Loss (Acoustic Trauma) 01/2021
1	Laryngeal Neoplasms (Laryngeal Cancer) 11/2020
1	Infections 09/2019
1	Chronic Renal Insufficiency 09/2019
1	Diabetes Mellitus 01/2019
1	Mouth Neoplasms (Oral Cancer) 01/2019
1	Nasopharyngeal Carcinoma 01/2019
1	Squamous Cell Carcinoma of Head and Neck 01/2019
1	Adenocarcinoma 12/2018
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2018
1	Otomycosis 04/2017
1	Allergic Rhinitis 04/2016
1	Abscess 12/2011
1	Tularemia 12/2011
1	High-Frequency Hearing Loss 12/2011
1	Lymphadenopathy 12/2011

3	Acetylcysteine (Siran)FDA LinkGeneric 01/2018 - 12/2011
3	Amikacin (A.M.K)FDA LinkGeneric 01/2018 - 12/2011
2	AminoglycosidesIBA 01/2018 - 12/2011
2	AntioxidantsIBA 01/2018 - 12/2011
2	Anti-Bacterial Agents (Antibiotics)IBA 10/2015 - 12/2011
1	3- (2- (2,4,6- trimethylphenyl)thioethyl)- 4- methylsydnoneIBA 07/2021
1	salicylhydroxamic acid (SHAM)IBA 07/2021
1	Glutamic Acid (Glutamate)FDA Link 01/2021
1	NeurosteroidsIBA 01/2021
1	gamma-Aminobutyric Acid (GABA)IBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 08/2019
1	QuercetinIBA 08/2019
1	Monoclonal AntibodiesIBA 01/2019
1	Nystatin (Mycostatin)FDA LinkGeneric 04/2017
1	Type A Botulinum Toxins (Botox)FDA Link 04/2016
1	Cysteine (L-Cysteine)FDA Link 10/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2015
1	Oxidants (Oxidizing Agents)IBA 10/2015
1	OzoneIBA 07/2013
1	Betahistine (Serc)IBA 07/2013
1	Vancomycin FDA LinkGeneric 12/2011
1	beta Lactam AntibioticsIBA 12/2011

3	Continuous Ambulatory Peritoneal Dialysis (CAPD) 09/2019 - 12/2011
2	Therapeutics 01/2019 - 01/2019
2	Craniotomy 12/2018 - 12/2011
1	Conservative Treatment 02/2022
1	Transcranial Magnetic Stimulation 07/2021
1	Radiotherapy 11/2020
1	General Anesthesia 01/2019
1	Free Tissue Flaps 01/2019
1	Peritoneal Dialysis 10/2015
1	Aftercare (After-Treatment) 07/2013